Nick Pizzie

Companies

• Axsome TherapeuticsChief financial officer May 29, 2018 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAxsome Therapeutics AXSM43,355 shares²$6.8M at $155.73Jun 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 9, 2026Sold 33,000 shares at $240.09 of Axsome Therapeutics²
• Jun 9, 2026Exercised options 33,000 shares at $3.50 of Axsome Therapeutics²
• Jan 22, 2026Sold 12,000 shares at $187.92 of Axsome Therapeutics³
• Jan 22, 2026Exercised options 12,000 shares at $3.50 of Axsome Therapeutics³
• Feb 14, 2025Sold 3,000 shares at $131.07 of Axsome Therapeutics⁴
• Feb 14, 2025Exercised options 3,000 shares at $3.50 of Axsome Therapeutics⁴
• Feb 13, 2025Sold 12,000 shares at $129.86 of Axsome Therapeutics⁴
• Feb 13, 2025Exercised options 12,000 shares at $3.50 of Axsome Therapeutics⁴
• Nov 18, 2021Bought 142 shares at $35.20 of Axsome Therapeutics⁵
• Nov 18, 2021Bought 145 shares at $34.30 of Axsome Therapeutics⁵
• Nov 18, 2021Bought 141 shares at $35.43 of Axsome Therapeutics⁵
• Nov 18, 2021Bought 527 shares at $35.50 of Axsome Therapeutics⁵